Chemotherapy-free treatment with acalabrutinib can benefit patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN study
Year: 2025
Type: article
Abstract: patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN study,
Source: Future Oncology
Authors: Jeff P. Sharman, Shweta Hakre
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: AstraZeneca
OpenAlex ID: W4407980292
